Camila Manrique Acevedo
University of Missouri-Columbia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Camila Manrique Acevedo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:56 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT03837626 · ENAC Blockade and Arterial StiffnessUniversity of Missouri-Columbia · completed · Overweight and Obesity, Insulin Resistance · principal investigator
- N/ANCT03785470 · Vascular and Metabolic Consequences of Adopting a Westernized LifestyleUniversity of Missouri-Columbia · completed · Vascular Diseases · principal investigator
- Ph2NCT03648996 · Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric AcidUniversity of Missouri-Columbia · completed · Diabetes Mellitus, Type 2, Hyperuricemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- SGLT2 inhibition as a therapeutic strategy to reverse arterial stiffening in agingR01AG082413 · NIA · UNIVERSITY OF MISSOURI-COLUMBIA · fiscal years 2024 to 2026 · $603,556 awarded in 2026Same name and institution; not confirmed by an ID
- Estrogen receptor alpha signaling in endothelial cells exacerbates arterial stiffening via upregulation of ENaC in insulin resistant femalesR01HL142770 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · fiscal years 2019 to 2023 · $614,943 awarded in 2023Same name and institution; not confirmed by an ID
- Sex-related differences in arterial stiffness in type 2 diabetics: role of uric acidR21DK116081 · NIDDK · UNIVERSITY OF MISSOURI-COLUMBIA · fiscal years 2018 to 2020 · $193,750 awarded in 2020Same name and institution; not confirmed by an ID
- Mineralocorticoid and estrogen receptor alpha signaling in the pathogenesis of vascular stiffness in insulin resistant femalesK08HL129074 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · fiscal years 2015 to 2019 · $169,376 awarded in 2019Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.